AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 56 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,798 | +589.0% | 20,592 | -81.6% | 24.67% | +523.2% |
| Q2 2023 | $50,476 | +55.3% | 112,044 | 0.0% | 3.96% | +121.3% |
| Q1 2023 | $32,493 | -35.6% | 112,044 | 0.0% | 1.79% | +165.0% |
| Q4 2022 | $50,420 | -14.5% | 112,044 | 0.0% | 0.68% | -16.0% |
| Q3 2022 | $59,000 | +3.5% | 112,044 | 0.0% | 0.80% | -8.8% |
| Q2 2022 | $57,000 | -77.9% | 112,044 | 0.0% | 0.88% | -74.7% |
| Q1 2022 | $258,000 | -51.5% | 112,044 | 0.0% | 3.49% | -43.5% |
| Q4 2021 | $532,000 | -40.3% | 112,044 | 0.0% | 6.17% | -59.7% |
| Q3 2021 | $891,000 | +14.2% | 112,044 | 0.0% | 15.31% | +73.7% |
| Q2 2021 | $780,000 | -12.1% | 112,044 | 0.0% | 8.82% | +280.8% |
| Q1 2021 | $887,000 | -66.5% | 112,044 | -66.7% | 2.32% | -46.3% |
| Q4 2020 | $2,646,000 | – | 336,132 | – | 4.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |